Rockland Immunochemicals Acquires TrueBlot® Product Line
GILBERTSVILLE, Pa.--(BUSINESS WIRE)--Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, assay development, and preclinical studies, today announced the acquisition of the TrueBlot® IP/Western blot product line from eBioscience, Inc., an Affymetrix (NASDAQ:AFFX) company.